Analyst Reco. Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 08:43:21 24/04/2025 BST			5-day change	1st Jan Change
1,317.25 ^DKK	-0.96%		+2.86%	-12.19%

04-22	Goldman Sachs lowers target price for Genmab to DKK 1,764 (1,841), reiterates neutral - BN	FW
04-16	BNP Paribas Exane lowers target price for Genmab to DKK 1,300 (1,400), reiterates neutral - BN	FW

Analyst Reco.

Goldman Sachs lowers target price for Genmab to DKK 1,764 (1,841), reiterates neutral - BN	04-22	FW
BNP Paribas Exane lowers target price for Genmab to DKK 1,300 (1,400), reiterates neutral - BN	04-16	FW
Bernstein Downgrades Genmab to Underperform, Cuts PT	04-01	MT
Bernstein downgrades Genmab to underperform (market perform), target price DKK 1,000 (1,580) - BN	04-01	FW
BNP Paribas Exane lowers target price for Genmab to DKK 1,400 (1,500), reiterates neutral - BN	03-12	FW
William Blair Upgrades Genmab to Outperform From Market Perform	03-11	MT
RBC Cuts Price Target on Genmab to DKK2,300 From DKK2,400, Keeps Outperform Rating	03-11	MT
Goldman Sachs lowers target price for Genmab to DKK 1,841 (2,064), reiterates neutral - BN	03-11	FW
Sydbank lowers Genmab to keep (buy) - BN	03-11	FW
SEB lowers target price for Genmab to DKK 2,300 (2,500), reiterates Buy - BN	03-11	FW
Deutsche Bank lowers target price for Genmab to DKK 1,900 (2,100), reiterates Buy	03-11	FW
RBC lowers target price for Genmab to DKK 2,300 (2,400), reiterates outperform - BN	03-11	FW
Truist Lowers Price Target on Genmab to $45 From $50, Maintains Buy Rating	03-10	MT
Goldman Sachs lowers target price for Genmab to DKK 2,064 (2,066), reiterates neutral - BN	03-07	FW
Kempen raises target price for Genmab to DKK 3,070 (2,950), reiterates Buy - BN	02-19	FW
Deutsche Bank lowers target price for Genmab to DKK 2,100 (2,250), reiterates Buy	02-17	FW
GENMAB : Good end to 2024	02-13
Leerink Upgrades Genmab to Outperform From Market Perform, Price Target is $27	02-13	MT
Cowen lowers target price for Genmab to DKK 1,431 (1,806), reiterates Hold - BN	02-13	FW
BNP Paribas Exane Upgrades Genmab to Neutral, Cuts PT	02-11	MT
BNP Paribas Exane upgrades Genmab to neutral (underperform), target price DKK 1,500 - BN	02-11	FW
Carnegie lowers target price for Genmab to DKK 2,647 (2,658), reiterates Buy - BN	02-11	FW
Goldman Sachs lowers target price for Genmab to DKK 2,066 (2,425), reiterates neutral - BN	01-24	FW
Bernstein Upgrades Genmab to Market Perform, Lowers PT	12-20	MT
Bernstein upgrades Genmab to market perform (underperform), target price DKK 1,580 (1,600) - BN	12-20	FW

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab: From now on, courage to the most patient

April 01, 2025 at 03:57 pm

GENMAB : Good end to 2024

February 13, 2025 at 07:48 pm